Filter By Industry
Filter By Tag

Newsroom

Sentynl Therapeutics, Inc. Press releases

1 - 1 of 1 Press Release

Sentnyl Therapeutics, Inc. Re-Launches Abstral® in the United States
Apr 29, 2016
Sentynl Therapeutics, Inc. ("Sentynl") announced that its commercial organization relaunched Abstral® in the United States. Sentynl acquired the rights to market Abstral® from Galena Biopharma in November 2015.


Sentynl Therapeutics, Inc. RSS Feed